Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 539540, 8 pages
http://dx.doi.org/10.1155/2014/539540
Research Article

Therapeutic Efficacy of Vitamin E -Tocotrienol in Collagen-Induced Rat Model of Arthritis

1Discipline of Physiology and Pharmacology, School of Veterinary and Biomedical Sciences, Faculty of Medicine, Health and Molecular Sciences, James Cook University, Townsville QLD 4811, Australia
2Department of Pathology, Faculty of Medicine, International Medical University, 57000 Kuala Lumpur, Malaysia
3Perdana University Graduate School of Medicine, 57000 Kuala Lumpur, Malaysia

Received 14 February 2014; Revised 17 June 2014; Accepted 25 June 2014; Published 10 July 2014

Academic Editor: Anca Irinel Catrina

Copyright © 2014 Nagaraja Haleagrahara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. H. Toh, S. Sengupta, A. H. Ang, J. C. White, and K. S. Lau, “Pattern of rheumatoid arthritis in West Malaysia,” Annals of the Rheumatic Diseases, vol. 32, no. 2, pp. 151–156, 1973. View at Google Scholar
  2. C. A. Smith and F. C. Arnett, “Epidemiologic aspects of rheumatoid arthritis. Current immunogenetic approach,” Clinical Orthopaedics and Related Research, vol. 265, pp. 23–35, 1991. View at Google Scholar
  3. S. Chaiamnuay and S. L. Bridges Jr., “The role of B cells and autoantibodies in rheumatoid arthritis,” Pathophysiology, vol. 12, no. 3, pp. 203–216, 2005. View at Publisher · View at Google Scholar
  4. E. Romas, M. T. Gillespie, and T. J. Martin, “Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis,” Bone, vol. 30, no. 2, pp. 340–346, 2002. View at Google Scholar
  5. E. K. Kalra, “Nutraceutical—definition and introduction,” AAPS PharmSciTech, vol. 5, no. 3, article E25, 2003. View at Google Scholar
  6. G. B. Lockwood, “The quality of commercially available nutraceutical supplements and food sources,” The Journal of Pharmacy and Pharmacology, vol. 63, no. 1, pp. 3–10, 2011. View at Google Scholar
  7. K. Sundram, R. Sambanthamurthi, and Y. A. Tan, “Palm fruit chemistry and nutrition,” Asia Pacific Journal of Clinical Nutrition, vol. 12, no. 3, pp. 355–362, 2003. View at Google Scholar
  8. A. Kamal-Eldin and L. A. Appelqvist, “The chemistry and antioxidant properties of tocopherols and tocotrienols,” Lipids, vol. 31, no. 7, pp. 671–701, 1996. View at Publisher · View at Google Scholar
  9. P. Ramdas, M. Rajihuzzaman, S. D. Veerasenan, K. R. Selvaduray, K. Nesaretnam, and A. K. Radhakrishnan, “Tocotrienol-treated MCF-7 human breast cancer cells show down-regulation of API5 and up-regulation of MIG6 genes,” Cancer Genomics Proteomics, vol. 8, no. 1, pp. 19–31, 2011. View at Google Scholar
  10. N. A. Kelsey, H. M. Wilkins, and D. A. Linseman, “Nutraceutical antioxidants as novel neuroprotective agents,” Molecules, vol. 15, no. 11, pp. 7792–7814, 2010. View at Publisher · View at Google Scholar
  11. M. P. Vierboom, E. Breedveld, I. Kondova, and B. A. 't Hart, “Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis,” Arthritis Research & Therapy, vol. 12, no. 5, article R200, 2010. View at Google Scholar
  12. J. P. Portanova, Y. Zhang, G. D. Anderson et al., “Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo,” The Journal of Experimental Medicine, vol. 184, no. 3, pp. 883–891, 1996. View at Publisher · View at Google Scholar
  13. C. Steffen and R. Timpl, “Antigenicity of collagen and its application in the serological investigation of rheumatoid arthritis sera,” International Archives of Allergy and Applied Immunology, vol. 22, pp. 333–349, 1963. View at Google Scholar
  14. D. L. Asquith, A. M. Miller, I. B. McInnes, and F. Y. Liew, “Animal models of rheumatoid arthritis,” European Journal of Immunology, vol. 39, no. 8, pp. 2040–2044, 2009. View at Google Scholar
  15. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “Immunopathogenesis of collagen arthritis,” Springer Seminars in Immunopathology, vol. 25, no. 1, pp. 3–18, 2003. View at Publisher · View at Google Scholar
  16. M. Ueno, K. Imaizumi, T. Sugita, I. Takata, and M. Takeshita, “Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis,” International Journal of Immunopharmacology, vol. 17, no. 7, pp. 597–603, 1995. View at Google Scholar
  17. K. S. Ahn, G. Sethi, K. Krishnan, and B. B. Aggarwal, “Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis,” The Journal of Biological Chemistry, vol. 282, no. 1, pp. 809–820, 2007. View at Google Scholar
  18. A. A. Qureshi, J. C. Reis, C. J. Papasian, D. C. Morrison, and N. Qureshi, “Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice,” Lipids in Health and Disease, vol. 9, no. 1, p. 143, 2010. View at Publisher · View at Google Scholar
  19. A. A. Qureshi, J. C. Reis, N. Qureshi, C. J. Papasian, D. C. Morrison, and D. M. Schaefer, “δ- tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens,” Lipids in Health and Disease, vol. 10, article 39, 2011. View at Google Scholar
  20. C. W. Chen and H. H. Cheng, “A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes,” The Journal of Nutrition, vol. 136, no. 6, pp. 1472–1476, 2006. View at Google Scholar
  21. P. Palozza, S. Verdecchia, L. Avanzi et al., “Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells,” Molecular and Cellular Biochemistry, vol. 287, no. 1-2, pp. 21–32, 2006. View at Publisher · View at Google Scholar
  22. M. L. Yam, S. R. Abdul Hafid, H. M. Cheng, and K. Nesaretnam, “Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages,” Lipids, vol. 44, no. 9, pp. 787–797, 2009. View at Publisher · View at Google Scholar
  23. H. Akama and S. Saito, “Glucosamine and chondroitin for osteoarthritis,” Arthritis & Rheumatology, vol. 45, no. 1, p. 107, 2001. View at Google Scholar
  24. K. Kannan, R. A. Ortmann, and D. Kimpel, “Animal models of rheumatoid arthritis and their relevance to human disease,” Pathophysiology, vol. 12, no. 3, pp. 167–181, 2005. View at Google Scholar
  25. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura, “Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice,” Journal of Immunology, vol. 171, no. 11, pp. 6173–6177, 2003. View at Google Scholar
  26. T. Tomita, Y. Kakiuchi, and P. S. Tsao, “THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis,” Arthritis Research & Therapy, vol. 8, no. 1, article R7, 2006. View at Google Scholar
  27. T. Ostberg, H. Wahamaa, K. Palmblad et al., “Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis,” Arthritis Research & Therapy, vol. 10, no. 1, p. R1, 2008. View at Google Scholar
  28. U. Andersson and K. J. Tracey, “HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis,” Rheumatic Diseases Clinics of North America, vol. 30, no. 3, pp. 627–637, 2004. View at Google Scholar
  29. A. Skapenko, J. Leipe, P. E. Lipsky, and H. Schulze-Koops, “The role of the T cell in autoimmune inflammation,” Arthritis Research & Therapy, vol. 7, supplement 2, pp. S4–S14, 2005. View at Google Scholar
  30. C. D. Poole, P. Conway, A. Reynolds, and C. J. Currie, “The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study,” BMC Musculoskeletal Disorders, vol. 9, p. 146, 2008. View at Google Scholar
  31. E. Larsson, H. Erlandsson Harris, J. C. Lorentzen, A. Larsson, B. Mansson, and L. Klareskog, “Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats,” Rheumatology, vol. 41, no. 9, pp. 996–1000, 2002. View at Google Scholar
  32. D. J. Brull, N. Serrano, F. Zito et al., “Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 11, pp. 2063–2069, 2003. View at Google Scholar